Is Novanta undervalued or overvalued?
As of 2025-03-26, the Intrinsic Value of Novanta Inc (NOVT) is 107.45 USD. This Novanta valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 137.51 USD, the upside of Novanta Inc is -21.90%. This means that Novanta is overvalued by 21.90%.
The range of the Intrinsic Value is 69.43 - 228.06 USD
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 69.43 - 228.06 | 107.45 | -21.9% |
| DCF (Growth 10y) | 95.15 - 295.46 | 143.54 | 4.4% |
| DCF (EBITDA 5y) | 107.66 - 155.00 | 131.34 | -4.5% |
| DCF (EBITDA 10y) | 132.71 - 205.74 | 167.04 | 21.5% |
| Fair Value | 19.77 - 19.77 | 19.77 | -85.63% |
| P/E | 114.02 - 126.54 | 123.81 | -10.0% |
| EV/EBITDA | 59.30 - 106.47 | 82.48 | -40.0% |
| EPV | 33.15 - 50.23 | 41.69 | -69.7% |
| DDM - Stable | 16.11 - 63.69 | 39.90 | -71.0% |
| DDM - Multi | 49.80 - 159.11 | 76.60 | -44.3% |
| Market Cap (mil) | 4,944.86 |
| Beta | 1.28 |
| Outstanding shares (mil) | 35.96 |
| Enterprise Value (mil) | 4,944.86 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.13% |
| Cost of Debt | 5.42% |
| WACC | 8.78% |